Cecilie Abildgaard
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
-
- Melanoma and MAPK Pathways
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- Melanoma and MAPK Pathways 4
- RNA Research and Splicing 2
- Circular RNAs in diseases 2
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 2
- Co-authors
- Per Guldberg (7 shared papers)Christina Dahl (6 shared papers)Sílvia Regina Rogatto (7 shared papers)Luísa Matos do Canto (6 shared papers)Morten Skaugen (1 shared paper)Ingolf F. Nes (1 shared paper)Karina Dahl Steffensen (3 shared papers)Claus Christensen (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Oncotarget (2 papers)Cancers (2 papers)Clinical Epigenetics (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- DenmarkBrazilUnited States
In The Last Decade
Cecilie Abildgaard
17 papers receiving 566 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 202
- Molecular Biology 411
- Oncology 140
- Geriatrics and Gerontology 15
- Immunology 71
Countries citing papers authored by Cecilie Abildgaard
This map shows the geographic impact of Cecilie Abildgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecilie Abildgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecilie Abildgaard more than expected).
Fields of papers citing papers by Cecilie Abildgaard
This network shows the impact of papers produced by Cecilie Abildgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecilie Abildgaard. The network helps show where Cecilie Abildgaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Cecilie Abildgaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 154 | |
| 2 | 2015 | 100 | |
| 3 | 1997 | 56 | |
| 4 | 2020 | 40 | |
| 5 | 2014 | 40 | |
| 6 | 2023 | 35 | |
| 7 | 2014 | 34 | |
| 8 | 2022 | 33 | |
| 9 | 2018 | 30 | |
| 10 | 2021 | 14 | |
| 11 | 2017 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2020 | 8 | |
| 14 | 2019 | 4 | |
| 15 | 2024 | 2 | |
| 16 | 2021 | 1 | |
| 17 | 2024 | 1 |
About Cecilie Abildgaard
Cecilie Abildgaard is a scholar working on Molecular Biology, Cancer Research, Oncology, Biotechnology and Immunology, having authored 17 papers that have together received 575 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Melanoma and MAPK Pathways (4 papers), Cancer Research and Treatments (3 papers), MicroRNA in disease regulation (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Cutaneous Melanoma Detection and Management (2 papers), RNA Research and Splicing (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (202 citations), Molecular Biology (411 citations), Oncology (140 citations), Geriatrics and Gerontology (15 citations) and Immunology (71 citations). Cecilie Abildgaard has collaborated with scholars based in Denmark, Brazil and United States. Frequent co-authors include Per Guldberg, Christina Dahl, Sílvia Regina Rogatto, Luísa Matos do Canto, Morten Skaugen, Ingolf F. Nes, Karina Dahl Steffensen, Claus Christensen, Jiří Bártek and Martin Klíma. Their work appears in journals such as Journal of Clinical Oncology, Oncotarget, Cancers, Clinical Epigenetics and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.